Extrahepatic malignancies in metabolic dysfunction-associated fatty liver disease: A nationwide cohort study.
Min Kyung ParkMoon Haeng HurHye-Sung MoonHyunjae ShinSung Won ChungSungho WonYun Bin LeeEun-Ju ChoJeong-Hoon LeeSu Jong YuJung Hwan YoonYun Joon KimPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)
The diabetic or lean subtype of MAFLD was associated with a higher risk of extrahepatic malignancy than non-MAFLD. As MAFLD comprises a heterogeneous population, appropriate risk stratification and management based on the MAFLD subtypes are required.